Qiang Cai, MD
Gastroenterology · Shreveport, LANPI 1932112653
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,710 of the $14,230 with a category attached, or 61.2%. 29 manufacturers reported payments, led by AbbVie at 52.2% of the total. Reporting peaked in 2019 at $6,150 and has fallen 73.7% since, to $1,617 in 2025.
Across 314 payments — averaging $45.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Boston Scientific$824
- Johnson & Johnson$792
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$748
- Takeda Pharmaceuticals U.S.A., Inc.$674
- Conmed Corporation$608
- plus $3K from 23 others
Across 10 payments — averaging $6112.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$36K
- AbbVie$25K
What the payments were for
- Speaking & faculty fees$5,50039%
- Travel & lodging$210%
- Food & beverage$8,71061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 105 | $7,435 |
| Boston Scientific | 20 | $824 |
| Johnson & Johnson | 44 | $792 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $748 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $674 |
| Conmed Corporation | 3 | $608 |
| Gilead | 16 | $494 |
| ERBE USA Inc | 4 | $386 |
| Micro-tech Endoscopy USA, Inc. | 3 | $314 |
| Janssen Scientific Affairs, LLC | 4 | $307 |
| Sanofi | 6 | $291 |
| Regeneron Healthcare Solutions, Inc. | 4 | $235 |
| Daiichi Sankyo Inc. | 18 | $180 |
| Endogastric Solutions, Inc | 3 | $180 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Covidien LP | 1 | $120 |
| Pfizer | 5 | $85 |
| Mallinckrodt Hospital Products Inc. | 5 | $83 |
| Pentax Of America, Inc. | 1 | $69 |
| Madrigal Pharmaceuticals | 1 | $66 |
| Amgen | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Creo Medical Inc. | 1 | $27 |
| Bristol Myers Squibb | 1 | $20 |
| Merck | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Steris Corporation | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$5,720
- CONMED HEMOSTASIS$608
- XIFAXAN$375
- All Products$285
- VIO$161
- APC$161
- HYBRID KNIFE$161
- ERBEJET$161
- DUPIXENT$148
- STELARA$144
- ESOPHYX$132
- GATTEX$125
- ZEPOSIA$125
- Epclusa$125
- Barrx$120
- ACQUIRE$105
- EXALT$103
- VIO3$100
How this compares
$14,230 in reported general payments places this provider in the 80th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 100 | $1,574 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 58 | $975 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $785 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 45 | $693 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Shreveport
- Humberto AguilarShreveport$313K
- Hrishikesh SamantShreveport$81K
- Sathya JaganmohanShreveport$25K
- Elvin HardyShreveport$13K
- James MorrisShreveport$11K
- John ProvenzaShreveport$9K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
- Gia LandryBaton Rouge$511K
- Charles MonierThibodaux$448K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.